Mechanisms of Cell Volume Regulation in Liver

肝脏细胞体积调节机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): The ability to regulate volume is critical for the survival of cells. This is particularly true in the liver, which is subjected to dynamic changes in osmotic load as a result of its role in nutrient processing, metabolism, and bile formation. Loss of volume control leads to irreversible cell swelling that is a hallmark of acute and chronic liver injury. Given the importance of this problem, the goals of this project are to understand how hepatocyte volume, and by extension organ function, are maintained during osmotic stress. It is known that such stress imposes dramatic changes in cell architecture, and that plasma membrane ion channels are crucial to volume restoration after hepatocellular swelling. Recent work from this laboratory has suggested a novel role for the tyrosine kinase Src in coordinating these actions. This proposal will test the hypothesis that Src serves as a molecular switch that relays signals from volume-sensitive sensors to downstream effectors that reorganize the cytoskeleton and activate fluid and electrolyte movement through potassium and chloride channels, to maintain cell volume within a physiological state. The Specific Aims are: (1) to establish the kinetics and cellular localization of volume-sensitive Src activation, (2) to determine the role of Src in volume-sensitive cytoskeletal reorganization, and (3) to elucidate how Src regulates the activation of volume-sensitive ion channels. Studies in Aim 1 will determine how Src influences the volume-sensitive cellular localization and regulatory function of integrins, focal adhesion kinase (FAK), and the Src effectors Vav and phospholipase C (PLC) gamma. Studies in Aim 1 will also test whether the expression of Src influences outcome in an animal model of ischemia-reperfusion injury, a disorder manifested by pathological hepatocyte swelling. Studies in Aim 2 will determine whether inhibition of Src effectors modifies swelling-induced actin dynamics, and whether inhibition of these dynamics attenuates volume recovery. Studies in Aim 3 will test whether Src- dependent extracellular signal receptor (ERK) kinases are regulated upon swelling by PLC gamma and/or Vav, and whether the ERK effector phospholipase A2 regulates volume-sensitive potassium and chloride channels. The proposed studies will employ a variety of approaches, including live cell imaging, patch clamp recording, and in vivo and in vitro adenovirus gene delivery, to accomplish these aims. Collectively, these studies will provide an integrated picture of signaling pathways that are key to liver cell volume regulation under physiological conditions, and they will provide a basis for discovery of volume sensitive signaling proteins that serve cytoprotective roles during liver injury. Liver cells swell during the processing of nutrients, and to remain intact, they release salt and water to shrink back to their normal size. This project will examine how liver cells maintain their size and shape, which is essential for protection against liver injury produced by toxins or low blood flow. By identifying basic processes that prevent uncontrolled liver cell swelling, this research will provide important information for the development of effective drugs for treatment of liver injury.
描述(由申请人提供):调节体积的能力对于细胞的存活至关重要。这在肝脏中尤其如此,由于其在营养加工、代谢和胆汁形成中的作用,肝脏经受渗透负荷的动态变化。失去容量控制导致不可逆的细胞肿胀,这是急性和慢性肝损伤的标志。鉴于这个问题的重要性,本项目的目标是了解如何肝细胞体积,并通过扩展器官功能,保持在渗透压。众所周知,这种压力会使细胞结构发生巨大变化,并且质膜离子通道对肝细胞肿胀后的体积恢复至关重要。该实验室最近的工作表明,酪氨酸激酶Src在协调这些行动中发挥了新的作用。该提案将测试Src作为分子开关的假设,该分子开关将信号从体积敏感传感器传递到下游效应器,该下游效应器重组细胞骨架并通过钾和氯离子通道激活液体和电解质运动,以维持生理状态内的细胞体积。具体目标是:(1)建立容量敏感性Src激活的动力学和细胞定位,(2)确定Src在容量敏感性细胞骨架重组中的作用,(3)阐明Src如何调节容量敏感性离子通道的激活。目标1中的研究将确定Src如何影响整合素、粘着斑激酶(FAK)和Src效应物Vav和磷脂酶C(PLC)γ的体积敏感性细胞定位和调节功能。目的1中的研究还将测试Src的表达是否影响缺血-再灌注损伤的动物模型中的结果,缺血-再灌注损伤是一种表现为病理性肝细胞肿胀的病症。目标2中的研究将确定Src效应物的抑制是否改变肿胀诱导的肌动蛋白动力学,以及这些动力学的抑制是否减弱体积恢复。目的3中的研究将测试Src依赖性细胞外信号受体(ERK)激酶是否在肿胀时被PLC γ和/或Vav调节,以及ERK效应物磷脂酶A2是否调节体积敏感性钾和氯通道。拟议的研究将采用多种方法,包括活细胞成像,膜片钳记录,体内和体外腺病毒基因递送,以实现这些目标。总的来说,这些研究将提供一个完整的图片信号通路,是关键的生理条件下的肝细胞体积调节,他们将提供一个基础,发现体积敏感的信号蛋白,在肝损伤的细胞保护作用。肝细胞在处理营养物质的过程中膨胀,为了保持完整,它们释放盐和水以缩小到正常大小。该项目将研究肝细胞如何保持其大小和形状,这对于保护肝脏免受毒素或低血流量造成的肝损伤至关重要。通过确定防止不受控制的肝细胞肿胀的基本过程,这项研究将为开发治疗肝损伤的有效药物提供重要信息。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN D LIDOFSKY其他文献

STEVEN D LIDOFSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN D LIDOFSKY', 18)}}的其他基金

METFORMIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
二甲双胍治疗非酒精性脂肪性肝炎
  • 批准号:
    7206938
  • 财政年份:
    2005
  • 资助金额:
    $ 31.34万
  • 项目类别:
Metformin for the Treatment of Non-Alcoholic Steatohepatitis
二甲双胍治疗非酒精性脂肪性肝炎
  • 批准号:
    7041551
  • 财政年份:
    2004
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanisms of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    7802992
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanism of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    6915610
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanisms of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    7616129
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanism of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    6369827
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanism of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    6655535
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanisms of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    7366146
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanism of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    6517668
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:
Mechanism of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
  • 批准号:
    6767621
  • 财政年份:
    2001
  • 资助金额:
    $ 31.34万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 31.34万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了